Critical role of myeloid differentiation factor 88 in necrotizing enterocolitis

Pediatric Research

Volumn 75, Issue 6, 2014, Pages 707-715

  Yang, Guozhu ^a   Bao, Pingqian ^a   Zhang, Lie ^a   Lyu, Zhaoying ^a   Zhou, Bin ^a   Chen, Keling ^a   Peng, Su ^a   Wang, Yi ^a   Yao, Longpei ^a   Zhou, Yin ^a   Li, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BAX; PROTEIN BCL 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; MALE; MOUSE; NECROTIZING ENTEROCOLITIS; NEWBORN; NICK END LABELING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL LINE; CYTOKINES; ENTEROCOLITIS, NECROTIZING; ENTEROCYTES; IN SITU NICK-END LABELING; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84900874670     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.39     Document Type: Article

References (37)

1. Ryder RW, Shelton JD, Guinan ME. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980;112:113-23.
2. Uauy RD, Fanarof AA, Korones SB, Phillips EA, Phillips JB, Wright LL. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991;119:630-8.
3. Blakely ML, Lally KP, McDonald S, et al.; NEC Subcommittee of the NICHD Neonatal Research Network. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005;241:984-9; discussion 989-94.
4. Gagliardi L, Bellù R, Cardilli V, De Curtis M; Network Neonatale Lom-bardo. Necrotising enterocolitis in very low birth weight infants in Italy: incidence and non-nutritional risk factors. J Pediatr Gastroenterol Nutr 2008;47:206-10.
5. Leaphart CL, Cavallo J, Gribar SC, et al. A critical role for tLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007;179:4808-20.
6. Gribar SC, Sodhi CP, Richardson WM, et al. Reciprocal expression and signaling of tLR4 and tLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 2009;182:636-46.
7. Richardson WM, Sodhi C P, Russo A, et al. Nucleotide-binding oligomer-ization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 2010, 139: 904-917e6.
8. Sodhi C P, Shi XH, Richardson WM, et al. toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 2010;138:185-96.
9. Sodhi C P, Neal MD, Siggers R, et al. Intestinal epithelial toll-like receptor 4 regulates goblet cell development and is required for necrotizing entero-colitis in mice. Gastroenterology 2012;143:708-18.e1-5.
10. Afrazi A, Sodhi C P, Richardson W, et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: toll-like receptors and beyond. Pediatr Res 2011;69:183-8.
11. Yamamoto M, Sato S, Mori K, et al. Cutting edge: a novel toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the toll-like receptor signaling. J Immunol 2002;169:6668-72.
12. Larsson E, tremaroli V, Lee YS, et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 2012;61:1124-31.
13. Castoldi A, Braga t t, Correa-Costa M, et al. tLR2, tLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis. PLoS ONE 2012;7:e37584.
14. tchaptchet S, Gumenscheimer M, Kalis C, et al. tLR9-dependent and independent pathways drive activation of the immune system by Propioni-bacterium acnes. PLoS ONE 2012; 7: e39155.
15. Ciorba MA, Riehl TE, Rao MS, et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a tLR-2/cyclo-oxygenase-2-de- pendent manner. Gut 2012;61:829-38.
16. Ohnishi H, tochio H, Kato Z, et al. tRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88. PLoS ONE 2012;7:e38423.
17. Reis J, Hassan F, Guan XQ, et al. The immunoproteasomes regulate LPS-induced tRIF/tRAM signaling pathway in murine macrophages. Cell Biochem Biophys 2011;60:119-26.
18. Oshiumi H, Sasai M, Shida K, Fujita t, Matsumoto M, Seya t. tIR-con-taining adapter molecule (tICAM)-2, a bridging adapter recruiting to toll-like receptor 4 tICAM-1 that induces interferon-beta. J Biol Chem 2003;278:49751-62.
19. Fitzgerald KA, Rowe DC, Barnes BJ, et al. LPS-tLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters tRAM and tRIF. J Exp Med 2003;198:1043-55.
20. Clark K, takeuchi O, Akira S, Cohen P. The tRAF-associated protein tANK facilitates cross-talk within the IkappaB kinase family during tolllike receptor signaling. Proc Natl Acad Sci USA 2011;108:17093-8.
21. Ogasawara N, Sasaki M, Itoh Y, et al. Rebamipide suppresses tLR-tBK1 signaling pathway resulting in regulating IRF3/7 and IFN-a/ß reduction. J Clin Biochem Nutr 2011;48:154-60.
22. Fornarino S, Laval G, Barreiro LB, Manry J, Vasseur E, Quintana-Murci L. Evolution of the tIR domain-containing adaptors in humans: swinging between constraint and adaptation. Mol Biol Evol 2011;28:3087-97.
23. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic infammatory diseases. N Engl J Med 1997;336: 1066-71.
24. Liu Y, Fatheree N Y, Mangalat N, Rhoads JM. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of tLR4 and NF-?B signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 2012;302:G608-17.
25. Deghmane AE, El Kafsi H, Giorgini D, Abaza A, taha MK. Late repression of NF-?B activity by invasive but not non-invasive meningococcal isolates is required to display apoptosis of epithelial cells. PLoS Pathog 2011;7:e1002403.
26. Hackam DJ, Upperman JS, Grishin A, Ford HR. Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005;14:49-57.
27. Li JH, D'Alessio A, Pober JS. Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells. Am J Pathol 2009;175:1124-35.
28. tamura R, Kanda t, Imazeki F, et al. Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of toll-like receptor 4. J Infect Dis 2011; 204: 793-801.
29. Li Y, Si R, Feng Y, et al. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and toll-like receptor 4. J Biol Chem 2011;286:31308-19.
30. Ko MK, Saraswathy S, Parikh JG, Rao NA. The role of tLR4 activation in photoreceptor mitochondrial oxidative stress. Invest Ophthalmol Vis Sci 2011;52:5824-35.
31. Fukata M, Chen A, Klepper A, et al. Cox-2 is regulated by toll-like recep-tor-4 (tLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006;131:862-77.
32. He S, Liang Y, Shao F, Wang X. toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-medi-ated pathway. Proc Natl Acad Sci USA 2011;108:20054-9.
33. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi t, Dvorak B. Bifdobacterium bifdum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010;299:G1118-27.
34. Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G755-62.
35. Kawai t, Adachi O, Ogawa t, takeda K, Akira S. Unresponsiveness of MyD88-defcient mice to endotoxin. Immunity 1999;11:115-22.
36. Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of tLR3/tRIF-induced corneal infammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem 2008;283:3988-96.
37. Nadler E P, Dickinson E, Knisely A, et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enteroco-litis. J Surg Res 2000;92:71-7.